Medilux launching a monitoring device for tissue blood in Korea

Published: 2003-02-10 06:56:00

Updated: 2003-02-10 06:56:00

MediLux, one of Hanmi Pharm's subsidiaries, said on January 23 that it launched QFlow-500, a commercially available device that monitors human tissue blood flow in a continuous real time.

Reportedly, MediLux has collaborated with Hemedex of the US for the commercialization of QFlow-500 since N...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK